WHI
LXRX icon

William Harris Investors’s Lexicon Pharmaceuticals LXRX Stock Holding History

William Harris Investors’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-39,495
Closed -$318K – 92
2015
Q2 		$318K Sell
39,495
-1
-0% -$7 0.09% 73
2015
Q1 		$261K Hold
39,496
– – 0.07% 75
2014
Q4 		$252K Buy
39,496
+10,304
+35% +$83.1K 0.07% 74
2014
Q3 		$288K Hold
29,192
– – 0.09% 66
2014
Q2 		$329K Hold
29,192
– – 0.09% 68
2014
Q1 		$354K Hold
29,192
– – 0.1% 65
2013
Q4 		$368K Hold
29,192
– – 0.11% 62
2013
Q3 		$486K Hold
29,192
– – 0.15% 56
2013
Q2 		$443K Buy
+29,192
New +$444K 0.13% 59

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

William Harris Investors's LXRX Position: Q3 2015 in Review

William Harris Investors sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2015, closing a stake of 39,495 shares — an estimated $318K sold.

William Harris Investors first reported a position in LXRX in Q2 2013 and held it in 9 quarters. The position peaked at $486K in Q3 2013. 105 funds tracked by Wall St. Rank hold LXRX as of Q3 2015.

  • William Harris Investors reported no remaining Lexicon Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • William Harris Investors sold 39,495 Lexicon Pharmaceuticals shares in Q3 2015, an estimated $318K.
  • William Harris Investors first reported a position in Lexicon Pharmaceuticals in Q2 2013 and held it in 9 quarters.
  • William Harris Investors's Lexicon Pharmaceuticals position peaked at $486K in Q3 2013.
  • 105 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2015.

Based on William Harris Investors's 13F filing for Q3 2015, filed 4 Nov 2015.